120 related articles for article (PubMed ID: 24310279)
21. Semi-Quantitative Calculations of Primary Tumor Metabolic Activity Using F-18 FDG PET/CT as a Predictor of Survival in 92 Patients With High-Grade Bone or Soft Tissue Sarcoma.
Andersen KF; Fuglo HM; Rasmussen SH; Petersen MM; Loft A
Medicine (Baltimore); 2015 Jul; 94(28):e1142. PubMed ID: 26181552
[TBL] [Abstract][Full Text] [Related]
22. Primary tumor maximum standardized uptake value measured on 18F-fluorodeoxyglucose positron emission tomography-computed tomography is a prognostic value for survival in bile duct and gallbladder cancer.
Lee JY; Kim HJ; Yim SH; Shin DS; Yu JH; Ju DY; Park JH; Park DI; Cho YK; Sohn CI; Jeon WK; Kim BI
Korean J Gastroenterol; 2013 Oct; 62(4):227-33. PubMed ID: 24162710
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of preoperative [18-F] fluorodeoxyglucose (FDG) positron emission tomography (PET) imaging in patients with resectable soft tissue sarcomas.
Schwarzbach MH; Hinz U; Dimitrakopoulou-Strauss A; Willeke F; Cardona S; Mechtersheimer G; Lehnert T; Strauss LG; Herfarth C; Büchler MW
Ann Surg; 2005 Feb; 241(2):286-94. PubMed ID: 15650639
[TBL] [Abstract][Full Text] [Related]
24. Prediction of treatment outcomes in patients with chest wall sarcoma: evaluation with PET/CT.
Nishiyama Y; Tateishi U; Kawai A; Chuman H; Nakatani F; Miyake M; Terauchi T; Inoue T; Kim EE
Jpn J Clin Oncol; 2012 Oct; 42(10):912-8. PubMed ID: 22850222
[TBL] [Abstract][Full Text] [Related]
25. Body Mass Index with Tumor 18F-FDG Uptake Improves Risk Stratification in Patients with Breast Cancer.
Hyun SH; Ahn HK; Lee JH; Choi JY; Kim BT; Park YH; Im YH; Lee JE; Nam SJ; Lee KH
PLoS One; 2016; 11(10):e0165814. PubMed ID: 27798667
[TBL] [Abstract][Full Text] [Related]
26. Contribution of PET/CT to prediction of outcome in children and young adults with rhabdomyosarcoma.
Baum SH; Frühwald M; Rahbar K; Wessling J; Schober O; Weckesser M
J Nucl Med; 2011 Oct; 52(10):1535-40. PubMed ID: 21903740
[TBL] [Abstract][Full Text] [Related]
27. Is [F-18]-fluorodeoxy-D-glucose positron emission tomography of value in the management of patients with craniofacial bone sarcomas undergoing neo-adjuvant treatment?
Frezza AM; Beale T; Bomanji J; Jay A; Kalavrezos N; Dileo P; Whelan J; Strauss SJ
BMC Cancer; 2014 Jan; 14():23. PubMed ID: 24422949
[TBL] [Abstract][Full Text] [Related]
28. 18F-fluorodeoxythymidine PET for evaluating the response to hyperthermic isolated limb perfusion for locally advanced soft-tissue sarcomas.
Been LB; Suurmeijer AJ; Elsinga PH; Jager PL; van Ginkel RJ; Hoekstra HJ
J Nucl Med; 2007 Mar; 48(3):367-72. PubMed ID: 17332613
[TBL] [Abstract][Full Text] [Related]
29. Nasopharyngeal carcinoma: investigation of intratumoral heterogeneity with FDG PET/CT.
Huang B; Chan T; Kwong DL; Chan WK; Khong PL
AJR Am J Roentgenol; 2012 Jul; 199(1):169-74. PubMed ID: 22733909
[TBL] [Abstract][Full Text] [Related]
30. The role of pretreatment FDG-PET in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy.
Liu WS; Wu MF; Tseng HC; Liu JT; Weng JH; Li YC; Lee JK
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):561-6. PubMed ID: 21300483
[TBL] [Abstract][Full Text] [Related]
31. Post-treatment [¹⁸F]FDG maximum standardized uptake value as a prognostic marker of recurrence in endometrial carcinoma.
Chung HH; Kim JW; Kang KW; Park NH; Song YS; Chung JK; Kang SB
Eur J Nucl Med Mol Imaging; 2011 Jan; 38(1):74-80. PubMed ID: 20838994
[TBL] [Abstract][Full Text] [Related]
32. Value of 18F-fluorodeoxyglucose uptake in positron emission tomography/computed tomography in predicting survival in multiple myeloma.
Haznedar R; Akı SZ; Akdemir OU; Ozkurt ZN; Ceneli O; Yağcı M; Sucak GT; Unlü M
Eur J Nucl Med Mol Imaging; 2011 Jun; 38(6):1046-53. PubMed ID: 21287167
[TBL] [Abstract][Full Text] [Related]
33. Value of FDG PET/CT in Patient Management and Outcome of Skeletal and Soft Tissue Sarcomas.
Sheikhbahaei S; Marcus C; Hafezi-Nejad N; Taghipour M; Subramaniam RM
PET Clin; 2015 Jul; 10(3):375-93. PubMed ID: 26099673
[TBL] [Abstract][Full Text] [Related]
34. Can 18F-FDG-PET response during radiotherapy be used as a predictive factor for the outcome of head and neck cancer patients?
Farrag A; Ceulemans G; Voordeckers M; Everaert H; Storme G
Nucl Med Commun; 2010 Jun; 31(6):495-501. PubMed ID: 20351599
[TBL] [Abstract][Full Text] [Related]
35. (F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma.
Folpe AL; Lyles RH; Sprouse JT; Conrad EU; Eary JF
Clin Cancer Res; 2000 Apr; 6(4):1279-87. PubMed ID: 10778952
[TBL] [Abstract][Full Text] [Related]
36. Risk assessment in liposarcoma patients based on FDG PET imaging.
Brenner W; Eary JF; Hwang W; Vernon C; Conrad EU
Eur J Nucl Med Mol Imaging; 2006 Nov; 33(11):1290-5. PubMed ID: 16832631
[TBL] [Abstract][Full Text] [Related]
37. 18F-FDG/18F-FES standardized uptake value ratio determined using PET predicts prognosis in uterine sarcoma.
Yamamoto M; Tsujikawa T; Yamada S; Kurokawa T; Shinagawa A; Chino Y; Mori T; Kiyono Y; Okazawa H; Yoshida Y
Oncotarget; 2017 Apr; 8(14):22581-22589. PubMed ID: 28186981
[TBL] [Abstract][Full Text] [Related]
38. Enhanced [18F]fluorodeoxyglucose accumulation in the right ventricular free wall predicts long-term prognosis of patients with pulmonary hypertension: a preliminary observational study.
Tatebe S; Fukumoto Y; Oikawa-Wakayama M; Sugimura K; Satoh K; Miura Y; Aoki T; Nochioka K; Miura M; Yamamoto S; Tashiro M; Kagaya Y; Shimokawa H
Eur Heart J Cardiovasc Imaging; 2014 Jun; 15(6):666-72. PubMed ID: 24408936
[TBL] [Abstract][Full Text] [Related]
39. PET response criteria in solid tumors predicts progression-free survival and time to local or distant progression after chemotherapy with regional hyperthermia for soft-tissue sarcoma.
Fendler WP; Lehmann M; Todica A; Herrmann K; Knösel T; Angele MK; Dürr HR; Rauch J; Bartenstein P; Cyran CC; Hacker M; Lindner LH
J Nucl Med; 2015 Apr; 56(4):530-7. PubMed ID: 25722445
[TBL] [Abstract][Full Text] [Related]
40. FDG PET/CT imaging in primary osseous and soft tissue sarcomas: a retrospective review of 212 cases.
Charest M; Hickeson M; Lisbona R; Novales-Diaz JA; Derbekyan V; Turcotte RE
Eur J Nucl Med Mol Imaging; 2009 Dec; 36(12):1944-51. PubMed ID: 19593561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
